Clinical trial
Phase 1 Combination Study of MM-151 With MM-121, MM-141, or Trametinib
NCT02538627
Study timeline
Study start (unknown)2015-08-01Date precision: month
Registry last updated2017-09-05
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Colorectal Cancerunresolved
Non-small Cell Lung Cancerunresolved
Interventions
Sponsors & collaborators
Merrimack Pharmaceuticalslead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02538627 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.